Valentina Guarneri
瓦伦蒂娜·瓜尔内里
MD, PhD
Professor of Medical Oncology; Director, Breast Oncology Unit肿瘤内科学教授；乳腺肿瘤科主任
👥Biography 个人简介
Distinguished Italian breast oncologist and principal investigator of the NeoSphere trial that established pertuzumab plus trastuzumab plus docetaxel as the neoadjuvant standard for HER2+ breast cancer, enabling breast-conserving surgery.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
HER2+ Breast Cancer Neoadjuvant Therapy
Led the NeoSphere trial demonstrating dual HER2 blockade with pertuzumab and trastuzumab plus docetaxel significantly improved pathological complete response rates, establishing the neoadjuvant backbone for HER2+ early breast cancer.
Representative Works 代表性著作
Pertuzumab plus Trastuzumab plus Docetaxel for Operable HER2-Positive Breast Cancer (NeoSphere)
The Lancet Oncology (2012)
Pivotal neoadjuvant trial showing dual HER2 blockade doubled pCR rate in HER2+ breast cancer; follow-up confirmed survival benefit.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 瓦伦蒂娜·瓜尔内里 的研究动态
Follow Valentina Guarneri's research updates
留下邮箱，当我们发布与 Valentina Guarneri（University of Padua; Istituto Oncologico Veneto IRCCS）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment